A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...

Today, we uncover the extent of low-quality generic cancer medicines disseminated globally, see ACIP prepare to raise new ...

Best Buy ‘s home health subsidiary Current Health revealed it was once again an independent company run by cofounder Chris ...

Good morning. You’ve got barely two more days to nominate a promising young researcher for this year’s STAT Wunderkinds. Think postdocs, interns, fellows — they’re not in charge yet, but they will be ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

Insmed's CEO keeps a newspaper story from 2014 in his office. The headline: “Insmed joins the biotech trash heap.” Now, he hopes the company can be a $100 billion biotech.

Over the past few months, several op-eds and commentaries have offered solutions to keep U.S. science moving forward in the ...

Eric Green said the process leading to his ouster as a NIH institute director by the Trump administration remains "shrouded ...

State workers who for decades have been pivotal in identifying U.S. cancer trends, curbing new cases, and improving screening ...

Policymakers will need to address the true drivers of high drug prices here at home, while simultaneously pressing our allies ...

As federal grants to study the use of race in clinical algorithms dry up researchers are looking for other funding sources.

In the debate over Medicaid reform, one dubious claim keeps getting tossed around. But the evidence for it is weak.